[ad_1]
Dunbar CE, Excessive KA, Joung JK, Kohn DB, Ozawa Ok, Sadelain M. Gene remedy comes of age. Science. 2018;359:6372.
Safinya CR, Ewert Ok, Ahmad A, Evans HM, Raviv U, Needleman DJ, Lin AJ, Slack NL, George C, Samuel CE. Cationic liposome–nucleic acid complexes for gene supply and gene silencing. Philos Trans R Soc A. 2006;364:2573–96.
Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA supply. J Managed Launch. 2008;126:97–110.
Felgner JH, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M. Proc Natl Acad Sci USA. 1987;84:7413–7.
Radler JO, Koltover I, Salditt T, Safinya CR. Science. 1997;275:810.
Koltover I, Salditt T, Rädler JO, Safinya CR. An inverted hexagonal part of cationic liposome–DNA complexes associated to DNA launch and supply. Science. 1998;281:78–81.
Junquera E, Aicart E. Current progress in gene remedy to ship nucleic acids with multivalent cationic vectors. Adv Colloid Interface Sci. 2016;233:161–75.
de la Fuente-Herreruela D, Monnappa AK, Muñoz-Úbeda M, Morallón-Piña A, Enciso E, Sánchez L, Giusti F, Natale P, López-Montero I. Lipid–peptide bioconjugation by means of pyridyl disulfide response chemistry and its utility in cell concentrating on and drug supply. J Nanobiotechnol. 2019;17:77.
Farhood H, Serbina N, Huang L. The function of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene switch. Biochim Biophys Acta. 1995;1235:289–95.
Rappolt M, Hickel A, Bringezu F, Lohner Ok. Mechanism of the lamelar/inverse hexagonal part transition examined by excessive decision X-ray diffraction. Biophys J. 2003;84:3111–22.
Sarkar S, Tran N, Rashid MH, Le TC, Yarovsky I, Conn CE, Drummond CJ. Towards cell membrane biomimetic lipidic cubic phases: a high-throughput exploration of lipid compositional house. ACS Appl Bio Mater. 2019;2:182–95.
Leal C, Bouxsein NF, Ewert KK, Safinya CR. Extremely environment friendly gene silencing exercise of siRNA embedded in a nanostructured gyroid cubic lipid matrix. J Am Chem Soc. 2010;132:16841–7.
MartÃnez-Negro M, Kumar Ok, Barrán-Berdón AL, Datta S, Kondaiah P, Junquera E, Bhattacharya S, Aicart E. Environment friendly mobile knockdown mediated by siRNA nanovectors of gemini cationic lipids having delocalizable headgroups and oligo-oxyethylene spacers. ACS Appl Mater Interfaces. 2016;8:22113–26.
Damen M, Groenen AJJ, van Dongen SFM, Nolte RJM, Scholte BJ, Feiters MC. Transfection by cationic gemini lipids and surfactants. Med Chem Comm. 2018;9:1404–25.
Juliano RL. Elements affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv Drug Deliv Rev. 1988;2:31–54.
Yadav MR, Kumar M, Murumkar PR, Hazari PP, Mishra AK. Gemini amphiphile-based lipoplexes for environment friendly gene supply: synthesis, formulation improvement, characterization, gene transfection, and biodistribution research. ACS Omega. 2018;3:11802–16.
Allen TM, Hansen C, Martin F, Redemann C, Yau-Younger A. Liposomes containing artificial lipid derivatives of poly(ethylene glycol) present extended circulation half-lives in vivo. Biochim Biophys Acta. 1991;1066:29–36.
Bai J, Liu Y, Solar W, Chen J, Miller AD, Xu Y. Down-regulated lysosomal processing improved pegylated lipopolyplex-mediated gene transfection. J Gene Med. 2013;15:182–92.
Gjetting T, Arildsen NS, Christensen CL, Poulsen TT, Roth JA, Handlos VN, Poulsen HS. In Vitro and in Vivo Results of Polyethylene Glycol (PEG)-modified Lipid in DOTAP/cholesterol-mediated Gene Transfection. Int J Nanomedicine. 2010;5:371–83.
Bombelli C, Faggioli F, Luciani P, Mancini G, Sacco MG. PEGylated lipoplexes: preparation protocols affecting DNA condensation and cell transfection effectivity. J Med Chem. 2007;50:6274–8.
Muñoz-Úbeda M, Misra SK, Barrán-Berdón AL, Aicart-Ramos C, Sierra MB, Biswas J, Kondaiah P, Junquera E, Bhattacharya S, Aicart E. Why is much less cationic lipid required to arrange lipoplexes from plasmid DNA than linear DNA in gene remedy? J Am Chem Soc. 2011;133:18014–7.
Muñoz-Úbeda M, Misra SK, et al. How does the spacer size of cationic gemini lipids affect the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene remedy. Biomacromol. 2012;13:3926–37.
MartÃnez-Negro M, Kumar Ok, Barrán-Berdón AL, Datta S, Kondaiah P, Junquera E, Bhattacharya S, Aicart E. Environment friendly mobile knockdown mediated by siRNA nanovectors of gemini cationic lipids having delocalizable headgroups and oligooxyethylene spacers. ACS Appl Mater Interfaces. 2016;8:22113–26.
Kumar Ok, Barrán-Berdón AL, Datta S, Muñoz-Úbeda M, et al. A delocalizable cationic headgroup along with an oligooxyethylene spacer in gemini cationic lipids improves their organic exercise as vectors of plasmid DNA. J Mater Chem B. 2015;3:1495–506.
Misra SK, Muñoz-Úbeda M, Datta S, Barrán-Berdón AL, et al. Results of a delocalizable cation on the headgroup of gemini lipids on the Lipoplex-type nanoaggregates instantly fashioned from plasmid DNA. Biomacromol. 2013;14:3951–63.
Muñoz-Úbeda M, Tolosa-DÃaz A, Bhattacharya S, Junquera E, Aicart E, Natale P, López-Montero I. Gemini-based lipoplexes complement the mitocondrial phenotype in MFN1-Knockout Fibroblasts. Mol Pharm. 2019;16:4787–96.
Chan DC. Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol. 2006;22:79–99.
Olichon A, Emorine LJ, Descoins E, Pelloquin L, Brichese L, Luptak I, Guillou E, Delettre C, Valette A, Hamel CP, et al. The human dynamin—associated protein OPA1 is anchored to the mitochondrial inside membrane dealing with the inner-membrane house. FEBS Lett. 2002;523:171–6.
Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:207–10.
Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L. OPA1 requires mitofusin 1 to advertise mitochondrial fusion. Proc Natl Acad Sci USA. 2004; 101: 15927–15932.
Detmer SA, Chan DC. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects attributable to CMT2A illness mutations. J Cell Biol. 2007;176:405–14.
Cardoso AM, Morais CM, Cruz AR, Cardoso AL, Silva SG, Luisa M, Marques EF, Pedroso MC, Jurado AS. Gemini surfactants mediate environment friendly mitochondrial gene supply and expression. Mol Pharm. 2015;12:716–30.
Lin AJ, Slack NL, Ahmad A, George CX, Samuel CE, Safinya CR. Three-dimensional imaging of lipid gene-carriers: membrane cost density controls common transfection habits in lamellar cationic liposome-dna complexes. Biophys J. 2003;84:3307–16.
Mezzenga R, Meyer C, Servais C, Romoscanu AI, Sagalowicz L, Hayward RC. Shear rheology of lyotropic liquid crystals: a case research. Langmuir. 2005;21:3322–33.
Leung SSW, Leal C. The stabilization of primitive bicontinuous cubic phases with tunable swelling over a large composition vary. Smooth Matter. 2019;15:1269–77.
Briggs J, Chung H, Caffrey M. The temperature-composition part diagram and mesophase construction characterization of the monoolein/water system. J Phys. 1996;II(6):723–51.
Tyler AII, Barriga HMG, Parsons ES, McCarthy NLC, Ces O, Legislation RV, Seddon JM, Brooks NJ. Electrostatic swelling of bicontinuous cubic lipid phases. Smooth Matter. 2015;11:3279–86.
Bilalov A, Olsson U, Lindman B. A cubic DNA-Lipid advanced. Smooth Matter. 2009;5:3827–30.
Valente AJ, Maddalena LA, Robb EL, Moradi F, Stuart JA. A easy ImageJ macro software for analyzing mitochondrial community morphology in mammalian cell tradition. Acta Histochemia. 2017;119:315–26.
Delettre C, Griffoin JM, Kaplan J, Dolfus H, Lorenz B, Faivre L, Lenaers G, Belenguer P, Hamel CP. Mutation spectrum and splicing variants within the OPA1 gene. Hum Genet. 2001;109:584–91.
Akepati VR, Müller EC, Otto A, Strauss HM, Portwich M, Alexander C. Characterization of OPA1 isoforms remoted from mouse tissues. J Neurochem. 2008;106:372–83.
Music Z, Chen H, Fiket M, Alexander C, Chan DC. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol. 2007;178:749–55.
Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E, Langer T. The i-AAA protease YME1L and OMA1 cleave OPA1 to steadiness mitochondrial fusion and fission. J Cell Biol. 2014;204:919–29.
Lee H, Smith SB, Yoon Y. The quick variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae construction. J Biol Chem. 2017;292:7115–30.
Patten DA, Wong J, Khacho M, Soubannier V, Mailloux RJ, Pilon-Larose Ok, MacLaurin JG, Park DS, McBride HM, Trinkle-Mulcahy L, Harper ME, Germain M, Slack RS. OPA1-dependent cristae modulation is crucial for mobile adaptation to metabolic demand. EMBO. 2014;33:2676–91.
Del Dotto V, Mishra P, Vidoni S, Fogazza M, Maresca A, Caporali L, McCaffery JM, Cappelletti M, Baruffini E, Lenaers G, Chan D, Rugolo M, Carelli V, Zanna C. OPA1 isoforms within the hierarchical group of mitochondrial capabilities. Cell Rep. 2017;19:2557–71.
Nolan T, Fingers RE, Bustin SA. Quantification of mRNA utilizing real-time RT-PCR. Nat Protoc. 2006;1:1559–82.
Gene remedy medical trials worldwide to 2017: An replace
Li SD, Huang L. Non-viral Is Superior to Viral Gene Supply. J Management Launch. 2007;123:181–3.
Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA supply into grownup mice. Science. 1993;261:209–11.
Thierry AR, Lunardi-Iskandar Y, Bryant JL, Rabinovich P, Gallo RC, Mahan LC. Systemic gene remedy: biodistribution and long-term expression of a transgene in mice. PNAS. 1995;92:9742–6.
Liu Y, Liggitt D, Zhong W, Tu G, Gaensler Ok, Debs R. Cationic liposome-mediated intravenous gene supply. J Biol Chem. 1995;270:24864–70.
Parker SE, Ducharme S, Norman J, Wheeler CJ. Tissue distribution of the cytofectin part of a plasmid-DNA/cationic lipid advanced following intravenous administration in mice. Hum Gene Ther. 1997;8:393–401.
Liu F, Qi H, Huang L, Liu D. Elements controlling the effectivity of cationic lipid-mediated transfection in vivo by way of intravenous administration. Gene Ther. 1997;4:517–23.
Brigham KL, Meyrick B, Christman B, Magnuson M, King G, Berry LC. In vivo transfection of murine lungs with a functioning prokaryotic gene utilizing a liposome car. Am J Med Sci. 1989;298:278–81.
Mahato RI, Anwer Ok, Tagliaferri F, Meaney C, Leonard P, Wadhwa MS, Logan M, French M, Rolland A. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum Gene Ther. 1998;9:2083–99.
McClarrinon M, Gilkey L, Watral V, Fox B, Bullock C, Fradkin L, Liggitt D, Roche L, Bussey LB, Fox E, Gorman C. In Vivo Research of Gene Expression by way of Transient Transgenesis Utilizing lipid-DNA Supply. DNA Cell Biol. 1999;18:533–47.
Hofland HE, Nagy D, Liu JJ, Spratt Ok, Lee YL, Danos O, Sullivan SM. In vivo gene switch by intravenous administration of secure cationic lipid/DNA advanced. Pharm Res. 1997;14:742–9.
Music YK, Liu F, Chu S, Liu D. Characterization of cationic liposome mediated gene switch in vivo by intravenous administration. Hum Gene Ther. 1997;8:1585–94.
Barron LG, Gagné L, Szoka FC Jr. Lipoplex-mediated gene supply to the lung happens inside 60 minutes of intravenous administration. Hum Gene Ther. 1999;10:1683–94.
Opanasopit P, Nishikawa M, Hashida M. Elements affecting drug and gene supply: results of interplay with blood elements. Crit Rev Ther Drug Provider Syst. 2002;19:191–233.
Badea I, Verrall R, Baca-Estrada M, Tikoo S, Rosenberg A, Kumar P, Foldvari M. In vivo cutaneous interferon-gamma gene supply utilizing novel dicationic (gemini) surfactant-plasmid complexes. J Gene Med. 2005;7:1200–14.
Alqawlaq S, Sivak JM, Huzil JT, Ivanova MV, Flanagan JG, Beazely MA, Foldvari M. Preclinical improvement and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: in direction of non-invasive glaucoma gene remedy. Nanomedicine. 2014;10:1637–47.
Chien PY, Wang Y, Carbonaro D, Lei S, Miller B, Sheikh S, Ali SM, Ahmad MU, Ahmad I. Novel cationic cardiolipin analogue-based liposome for environment friendly DNA and small interfering RNA supply in vitro and in vivo. Most cancers Gene Ther. 2005;12:321–8.
Wasungu L, Scarzello M, van Dam G, Molema G, Wagenaar A, Engberts JBFN, Hoekstra D. Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene remedy functions. J Mol Med. 2006;84:774–84.
Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, Menabò R, Costa V, Civiletto G, Pesce P, Viscomi C, Zeviani M, Di Lisa F, Mongillo M, Sandri M, Scorrano L. The OPA1-dependent mitochondrial cristae transforming pathway controls atrophic, apoptotic, and ischemic tissue injury. Cell Metab. 2015;21:834–44.
Del Dotto V, Fogazza M, Lenaers G, Rugolo M, Carelli V, Zanna C. OPA1: how a lot do we all know to method remedy? Pharmacol Res. 2018;131:199–210.
Dotto V, Fogazza M, Carelli V, et al. Eight human OPA1 isoforms, lengthy and quick: What are they for? Bioenergetics. 2018;1859:263–9.
Petit L, Khanna H, Punzo C. Advances in gene remedy for ailments of the attention. Hum Gene Ther. 2016;27:563–79.
Yu-Wai-Man P, Votruba M, Burté F, La Morgia C, Barboni P, Carelli V. A neurodegenerative perspective on mitochondrial optic neuropathies. Acta Neuropathol (Berl). 2016;132:789–806.
Foldvari M, Chen DW, Nafissi N, Calderon D, Narsineni L, Rafiee A. Non-viral gene remedy: features and challenges of non-invasive administration strategies. J Management Launch. 2016;240:165–90.
Pal A, Datta S, Aswal VK, Bhattacharya S. Small-angle neutron-scattering research of combined micellar buildings manufactured from dimeric surfactants having imidazolium and ammonium headgroups. J Phys Chem B. 2012;116:13239–47.
Rodriguez-Pulido A, Aicart E, Llorca O, Junquera E. J Phys Chem B. 2008;112:2187–97.
Delgado AV. Interfacial electrokinetics and electrophoresis. New York: Marcel Dekker; 2002. p. 106.
Oshima H, Furusawa Ok. Electrical phenomena at interfaces fundamentals: measurements and functions. New York; Marcel Dekker; 1998.
[ad_2]
